T2D Clinical Trials

1 recruiting

T2D Trials at a Glance

94 actively recruiting trials for t2d are listed on ClinicalTrialsFinder across 6 cities in 32 countries. The largest study group is Not Applicable with 42 trials, with the heaviest enrollment activity in Seoul, Beijing, and Philadelphia. Lead sponsors running t2d studies include BrightGene Bio-Medical Technology Co., Ltd., Alnylam Pharmaceuticals, and Celltrion.

Treatments under study

About T2D Clinical Trials

Looking for clinical trials for T2D? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new T2D trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about T2D clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 94 trials

Recruiting
Phase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)
University Medical Centre Ljubljana90 enrolled1 locationNCT06613854
Recruiting
Not Applicable

Culturally Tailored Program for Food-Insecure Adults: SPICE-D

Type 2 Diabetes Mellitus (T2D)
Wake Forest University Health Sciences25 enrolled1 locationNCT07361341
Recruiting

Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus

DiabetesType 2 Diabetes Mellitus (T2DM)Diabetic Retinopathy
Yufan Wang2,920 enrolled3 locationsNCT06821399
Recruiting
Phase 1Phase 2

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Type 2 Diabetes Mellitus (T2DM)Obese or Overweight Healthy Volunteers
Alnylam Pharmaceuticals144 enrolled20 locationsNCT06845202
Recruiting
Phase 2

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)
Alnylam Pharmaceuticals40 enrolled1 locationNCT07465224
Recruiting
Not Applicable

Using Virtual Reality to Improve Medical Training

Type 2 Diabetes (T2DM)
Ohio University100 enrolled1 locationNCT07542834
Recruiting
Phase 1

Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers

Type 2 Diabetes Mellitus (T2DM)
Celltrion48 enrolled1 locationNCT07533539
Recruiting
Not Applicable

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease(CKD)Type 2 DM
Duke University420 enrolled6 locationsNCT06906640
Recruiting
Not Applicable

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease(CKD)Type 2 DM
Duke University750 enrolled6 locationsNCT06906627
Recruiting

Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)Exocrine Pancreatic Insufficiency (EPI)Pancreatogenic Diabetes Mellitus
West Kazakhstan Marat Ospanov Medical University310 enrolled1 locationNCT07512934
Recruiting
Early Phase 1

A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus

T2DM
The First Affiliated Hospital of Henan University of Science and Technology9 enrolled1 locationNCT07347080
Recruiting
Phase 4

The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)SemaglutideCaloric Restriction
Second Affiliated Hospital of Nanchang University100 enrolled1 locationNCT07272343
Recruiting
Not Applicable

Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia

SarcopeniaType 2 Diabetes Mellitus (T2DM)
yueh chu wu128 enrolled1 locationNCT07398495
Recruiting
Not Applicable

Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes

HypertensionType 2 Diabetes Mellitus (T2DM)
Johns Hopkins University80 enrolled1 locationNCT06921356
Recruiting
Not Applicable

Feasibility of a Tailored Online Self-compassion Intervention

Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus
Canterbury Christ Church University50 enrolled2 locationsNCT07051005
Recruiting

Polyphenol Metabotypes in People With Diabetes Type 2

Type 2 Diabetes Mellitus (T2DM)
University Hospital, Ghent100 enrolled2 locationsNCT06810635
Recruiting
Phase 1

A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Regend Therapeutics15 enrolled1 locationNCT07275788
Recruiting
Not Applicable

Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)Type 2 Diabetes
Stanford University30 enrolled1 locationNCT06836479
Recruiting
Phase 4

iGlarLixi CGM Study in Chinese T2D Individuals After OADs

Type 2 Diabetes (T2D)
Sanofi678 enrolled1 locationNCT06671587
Recruiting

Investigation of Motor Imagery Ability, Body Awareness and Cognitive Functions in Type 2 Diabetes Mellitus

Cognitive FunctionType 2 Diabetes Mellitus (T2DM)Motor İmagery Ability
Kutahya Health Sciences University100 enrolled1 locationNCT06588894